<i>In silico</i> activity profiling reveals the mechanism of action of antimalarials discovered in a high-throughput screen
David Plouffe(Genomics Institute of the Novartis Research Foundation), Elizabeth A. Winzeler(University of California San Diego), Nathanael S. Gray(Stanford University), Paul Anderson(Genomics Institute of the Novartis Research Foundation), Jeremy S. Caldwell(Genomics Institute of the Novartis Research Foundation), A. S. Nagle(Genomics Institute of the Novartis Research Foundation), Case W. McNamara(Genomics Institute of the Novartis Research Foundation), Arnab K. Chatterjee(Scripps Research Institute), Achim Brinker(Genomics Institute of the Novartis Research Foundation), Richard E. Trager(Genomics Institute of the Novartis Research Foundation), Jason Matzen(Genomics Institute of the Novartis Research Foundation), Peter G. Schultz(Scripps Research Institute), Tae‐gyu Nam(Hanyang University), Nobutaka Kato(Broad Institute), S. Frank Yan(University of Science and Technology of China), Yingyao Zhou(Genomics Institute of the Novartis Research Foundation), Jeff Janes(Genomics Institute of the Novartis Research Foundation), Kelli Kuhen(Genomics Institute of the Novartis Research Foundation), Francisco Adrián(HiFiBiO Therapeutics (United States)), Kerstin Henson(Genomics Institute of the Novartis Research Foundation)
Cited by 454
Related Papers
Organization of 'nanocrystal molecules' using DNA
|Nature|1996|3k
A Landscape of Pharmacogenomic Interactions in Cancer
|Cell|2016|2.3k
An ATP-competitive Mammalian Target of Rapamycin Inhibitor Reveals Rapamycin-resistant Functions of mTORC1
|Journal of Biological Chemistry|2009|1.8k
Genomic analysis of the host response to hepatitis C virus infection
|Proceedings of the National Academy of Sciences|2002|1.2k